March 12, 2018 / 7:31 AM / 6 months ago

BRIEF-Realm Therapeutics Says Phase 2 Study of PR013 Did Not Demonstrate Efficacy​

March 12 (Reuters) - Realm Therapeutics Plc:

* CLINICAL UPDATE INCLUDING PR013 PHASE II RESULTS

* ‍PHASE 2 STUDY OF PR013, TOPICAL OPHTHALMIC SOLUTION FOR TREATMENT OF ALLERGIC CONJUNCTIVITIS, DID NOT DEMONSTRATE EFFICACY​

* ‍REALM HAS DECIDED TO DISCONTINUE FURTHER DEVELOPMENT OF THIS PROGRAM​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below